Sobi moves into new global headquarters in Stockholm
Last week marked an exciting milestone in Sobi’s journey as we officially moved into our new global headquarters in the heart of Hagastaden, Stockholm, Sweden. This relocation represents the beginning of a new chapter in our growth and positions us in a prime environment to continue driving innovation in healthcare.
Our new office is located within an international hub, close to Sweden’s largest hospital and leading research institutions, allowing for enhanced collaboration with key stakeholders in the life sciences sector. This proximity will further strengthen our ability to advance treatments for people with rare diseases.
The decision to relocate to Hagastaden was driven by our commitment to fostering a dynamic and forward-thinking work environment. This move is not just about changing our address; it’s about embracing a space that aligns with our vision for the future as we continue to grow and evolve as an organisation.
Designed with the future in mind, the new office features a sleek design and modern layout that promotes comfort, teamwork and creativity. It is tailored to meet the needs of our evolving business while providing an inspiring workspace for our employees. At Sobi, the wellbeing and productivity of our employees are paramount, and we believe that a well-designed workspace is crucial for driving innovation and collaboration.
“The relocation of our headquarters marks the next step in Sobi’s growth journey. We are confident that the new office will help us continue to support people living with rare diseases and our customers in the best way possible, while also providing our employees with an environment conducive to innovation and growth,” says Christine Wesström, Head of Global Technical Operations and responsible for Facilities Sweden at Sobi.
We provide access to innovative treatments that transform life for people.
Our therapies are concentrated within the areas of Haematology, Immunology and Specialty Care.
We contribute to societies by improving access to treatment of rare diseases.
Every day, we work actively to find better ways to understand and meet patient needs.
Find out more about our business and financial performance.
Here we present current and past media releases, images and videos.
- About
- Therapeutic areas
- Medicines
- Stories
- Sustainability
- Careers
- Investors
- Media
- English
- Swedish